While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

GLP-1 agonists – of which Novo Nordisk’s Ozempic and Wegovy (semaglutide) and Eli Lilly’s Mounjaro (tirzepatide) are the most ...

If you said diabetes, you're right -- a new study finds diabetes costs $101 billion annually in diagnosis and treatment and ...

Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of multiple organ failure, septic shock, ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

Amgen stock tumbled late Tuesday on a report that its high-profile weight-loss shot, MariTide, could be linked to bone ...

Lifecore now operates at less than 35% utilization, meaning that it can almost triple revenue with virtually no additional ...

Nov. 12—WATERTOWN — The Fort Drum Regional Health Planning Organization and North Country Health Compass Partners have ...

The Company previously announced sham-implant adjusted preclinical weight loss of 20%, which is comparable to the weight loss produced from the semaglutide (active ingredient in Ozempic®/Wegovy®) ...

Every earnings season has its share of outperformers, companies that report blowout quarters and raise their forecasts. The ...